CMC Challenges During Accelerated Development of Human Cell & Gene Therapy Products - A CBER Perspective
Speaker Presentation Kwilas Anna US FDA 2020
CMC Challenges During Accelerated Development of Human Cell & Gene Therapy Products - A CBER Perspective